Neuronal vulnerability and multilineage diversity in multiple sclerosis | Nature
Immunopathology of multiple sclerosis | Nature Reviews Immunology
Frontiers | Multiple Sclerosis as a Syndrome—Implications for Future Management
The immunology of multiple sclerosis | Nature Reviews Immunology
Multiple sclerosis - The Lancet
Immune-cell crosstalk in multiple sclerosis
Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery
A molecular trio in relapse and remission in multiple sclerosis | Nature Reviews Immunology
Epidemiology and treatment of multiple sclerosis in elderly populations | Nature Reviews Neurology
New concepts in the immunopathogenesis of multiple sclerosis | Nature Reviews Neuroscience
Remyelination therapies: a new direction and challenge in multiple sclerosis | Nature Reviews Drug Discovery
Twin study reveals non-heritable immune perturbations in multiple sclerosis | Nature
Transcriptional analysis of targets in multiple sclerosis | Nature Reviews Immunology
Multiple sclerosis | Nature Reviews Disease Primers
Transcriptional analysis of targets in multiple sclerosis | Nature Reviews Immunology
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery
Epstein–Barr virus sparks brain autoimmunity in multiple sclerosis
Immunopathology of multiple sclerosis | Nature Reviews Immunology
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study | Nature Medicine
Multiple sclerosis enters a grey area
